Using WhatsApp chats to understand a new approach to HIV testing in children.
Published in Healthcare & Nursing
Improving HIV testing for children and adolescents is vitally important, because children and adolescents experience a disproportionate amount of HIV-related illness and death compared to adults. Although children and adolescents aged up to 19 years old were only 7% of the global population living with HIV in 2021, they represented 17% of HIV-related deaths. This is due, in part, to late diagnosis of HIV.
A new approach to finding undiagnosed children living with HIV, known as index-linked testing, has been recommended by the World Health Organisation to improve diagnosis rates. Index-linked testing involves targeting of HIV testing to children of people living with HIV (known as indexes). This focused approach has the potential to find more children living with HIV and be more cost-effective than blanket testing approaches.
The “Bridging the Gap in HIV Testing and Care for Children in Zimbabwe” (B-GAP) study evaluated index-linked HIV testing for children aged between two and 18 years old at nine primary care clinics, covering both rural and urban areas. People living with HIV in a household with one or more children of unknown HIV status, or with a known HIV negative result more than 6 months ago, were eligible to take part in the study. Those who consented to have children tested could choose either a test at the clinic, a test at home delivered by a community healthcare worker (HCW), or a test at home delivered by a caregiver using an oral HIV self-test. B-GAP provided an opportunity to examine implementation in-depth, so lessons could be learned for future roll-out.
The B-GAP team kept in touch via two long-running WhatsApp chats, one for the whole field team, and the other for the rural areas only. We used those WhatsApp chats, as well as field team logs, meeting minutes, and incident reports, to identify barriers and facilitators to scale-up of index-linked testing. Data from each source was analysed thematically.
The WhatsApp chats deepened our understanding of implementation. In the chats, the team often offered more comprehensive opinions on successes and challenges than in other sources. For example, one chat had detailed discussion on difficulties coordinating with partner organisations who were delivering HIV testing of children in the community. This clarified the underlying reasons why these challenges were occurring, such as differences in aims between the partner organisations and the research team, as well as resource constraints faced by partner organisations. The chats also provided a real-time and dynamic account of events, such as stock-outs of HIV test kits, over time.
However, WhatsApp chats required more effort to analyse than the other sources. As the chats were an informal record, sometimes it was challenging to work out what researchers were referring to in their messages. Unlike with the other sources, the team presumed readers had prior knowledge of what was being discussed, making it difficult for an outsider to follow the conversation. Moreover, sometimes researchers met face-to-face or communicated using other technology, which led to sudden jumps in the topics being covered in the chats.
Nonetheless, through analysing the WhatsApp chats and other sources, we identified a range of challenges to index-linked testing for children. These are illustrated in the flow diagram to the right. Some challenges were recognised barriers to provision of many forms of HIV testing, such as stock-outs of HIV test kits, difficulties reaching clinics, and stigma around HIV. However, we also identified some unexpected challenges, such as indexes sending someone else to the clinic on their behalf, and a lack of familiarity with oral HIV testing, which resulted in low uptake. As index-linked HIV testing for children is used more widely it will be critical to find ways to ensure these challenges can be overcome.
The WhatsApp chats gave us valuable insight into the barriers and facilitators of index-linked HIV testing. It is important to consider newer technologies and social media alongside traditional sources of data to fully capture the complexity of implementation of public health interventions. By doing so, we can more effectively address barriers to delivery of interventions and ultimately improve health outcomes.
Read more about the B-GAP study and its findings in the following publications:
- Delivery of index-linked HIV testing for children: learnings from a qualitative process evaluation of the B-GAP study in Zimbabwe
- Comparison of index-linked HIV testing for children and adolescents in health facility and community settings in Zimbabwe: findings from the interventional B-GAP study
- Addressing the challenges and relational aspects of index-linked HIV testing for children and adolescents: insights from the B-GAP study in Zimbabwe
- Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests
Katherine is a PhD student at Imperial College London. Her PhD focuses on the links between HIV, mental health, and quality of life in sub-Saharan Africa.
Follow the Topic
-
BMC Infectious Diseases
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Real world evidence studies with antivirals for SARS-CoV-2
BMC Infectious Diseases is calling for submissions to our Collection on Real world evidence studies with antivirals for SARS-CoV-2. The emergence of SARS-CoV-2 has necessitated the rapid development and deployment of antiviral treatments to combat COVID-19. Real world evidence studies play a crucial role in understanding the effectiveness and safety of these antiviral therapies in diverse populations and clinical settings. By analyzing data from health records, registries, and retrospective studies, researchers can provide insights into how these treatments perform outside of controlled clinical trials.
Advancing our collective understanding of antiviral treatments for SARS-CoV-2 is essential for optimizing therapeutic strategies and improving public health responses. Significant progress has been made in identifying effective antiviral agents and understanding their mechanisms of action. Furthermore, real world evidence has highlighted variations in treatment efficacy across different demographics and comorbidities, underscoring the need for personalized treatment approaches. Continued research in this area will help refine treatment protocols and inform public health policies, ultimately enhancing patient care and outcomes.
This Collection aims to gather high-quality research dedicated to the real world application of antiviral treatments for SARS-CoV-2. Our focus is on studies that utilize real world data to assess the effectiveness, safety, and long-term outcomes of these antiviral interventions. We are particularly interested in studies that leverage retrospective data, real world evidence, and robust analyses of health records and registries to provide insights into the effectiveness, safety, and long-term outcomes of antiviral therapies for COVID-19. We welcome submissions that explore a wide range of topics, including but not limited to:
Comparative effectiveness of antiviral agents in different patient subgroups
Retrospective analyses of health records to evaluate treatment outcomes
The impact of antiviral therapy on long-term COVID-19 sequelae in real world populations
Drug resistance mutations and treatment strategies in patients with immunocompromised COVID-19
Utilization of real world data to inform treatment guidelines and public health strategies
Safety profiles of antivirals in populations underrepresented in clinical trials
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
Publishing Model: Open Access
Deadline: Jun 30, 2025
Healthcare-associated infections
BMC Infectious Diseases is calling for submissions to our Collection on Healthcare-associated infections.
Healthcare-associated infections (HAIs) represent a significant challenge to patient safety and public health, affecting millions of patients worldwide each year. These infections, which can occur in various healthcare settings, including hospitals and long-term care facilities, encompass a range of conditions such as surgical site infections, catheter-associated infections, and ventilator-associated infections. The emergence of antibiotic-resistant pathogens has further complicated the landscape of HAIs, necessitating ongoing research and innovation in infection prevention and control strategies.
Advancing our collective understanding of healthcare-associated infections is crucial for developing effective interventions that can reduce their incidence and improve patient outcomes. Recent advances in this field include the implementation of improved infection control protocols, the use of advanced surveillance technologies, and the development of novel antimicrobial agents. These efforts have shown promise in mitigating the impact of HAIs, but continued research is essential to address the evolving challenges posed by emerging pathogens and to refine existing strategies.
Ongoing research in healthcare-associated infections may lead to advancements in personalized infection prevention strategies, improved diagnostic tools, and the integration of artificial intelligence in infection surveillance. Such innovations could significantly boost our ability to predict, prevent, and manage HAIs, ultimately leading to safer healthcare environments.
This Collection aims to enhance understanding and improve practices in healthcare-associated infections management. Key topics of interest for submission include, but are not limited to:
Strategies for preventing surgical site infections
Trends in catheter-associated infections
Impact of antibiotic resistance on nosocomial infections
Innovations in infection control practices
Surveillance methods for healthcare-associated infections
This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Oct 31, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in